Delivery Order SPE2DB24D3013-SPE2DB25FFNXM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,226.52 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution...
- The Defense Logistics Agency awarded a $37,508.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitively awarded contract, which carries no set-aside designation, was finalized on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant commonly prescribed for rheumatoid...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $32,259.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a competitive award to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a $35,070.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of July 23, 2025. This non-set-aside contract was competitively awarded on July 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,327.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, non-set-aside contract represents a small-value transaction typical of the agency's pharmaceutical procurement activities. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,541.06 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of July 31, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,265.30 for Enbrel 50 mg/mL SureClick auto-injectors on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $18,530.12 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle supporting federal pharmaceutical procurement requirements....
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNXMDelivery Order
The Defense Logistics Agency awarded a $5,977.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of August 1, 2025. The award, issued on July 31, 2025, represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Enbrel is a TNF inhibitor used in treating rheumatoid arthritis and other inflammatory conditions, making this delivery order part of the company's broader portfolio supplying specialty medications and medical commodities across multiple therapeutic domains. The firm fixed-price delivery order structure demonstrates the company's established capability to fulfill federal medical supply requirements through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/31/25 |